A tablet of flibanserin sits on a brochure for Sprout …
Photo detail

AP FILE PHOTO, SEPT. 27 | published: December 12, 2013

A tablet of flibanserin sits on a brochure for Sprout Pharmaceuticals in the company’s Raleigh, N.C., headquarters. Sprout Pharmaceuticals said Wednesday that it has reached an impasse with the Food and Drug Administration over flibanserin.